0001104659-24-073943.txt : 20240621
0001104659-24-073943.hdr.sgml : 20240621
20240621161813
ACCESSION NUMBER: 0001104659-24-073943
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peters Richard
CENTRAL INDEX KEY: 0001697628
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 241060435
MAIL ADDRESS:
STREET 1: MERRIMACK PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
BUSINESS PHONE: 617-463-9385
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
4
1
tm2417666-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-20
0
0001781983
Aprea Therapeutics, Inc.
APRE
0001697628
Peters Richard
3805 OLD EASTON ROAD
DOYLESTOWN
PA
18902
1
0
0
0
0
Common Stock
2024-06-20
4
A
0
1045
0.00
A
2074
D
Stock Options (Right to Buy)
4.07
2024-06-20
4
A
0
4185
0.00
A
2034-06-20
Common Stock
4185
4185
D
These shares represent restricted stock units which were granted on June 20, 2024, and which will vest and be settled in common stock on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
The option vests in full on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
/s/ John Hamill, as Attorney-in-Fact
2024-06-21